Katie Thurston — who was diagnosed with stage 4 breast cancer after the disease spread to her liver — opened up about her ...

The dose of paclitaxel used in the new approach was 16-fold lower than that typically used in free paclitaxel, but with similar efficacy.

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

A Peter Mac-led international clinical trial has found a way to personalize treatment for gastroesophageal cancer, ...

Elena Adams said she was put on temozolomide within days of being diagnosed with a brain tumour in 2016. Guidelines say the ...

Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with ...

Yelena Y. Janjigian, MD, discusses the long-term survival data from the KEYNOTE-811 trial of pembrolizumab plus trastuzumab ...

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

Dave Coulier, best known for Full House, recently opened up about his battle with stage 3 non-Hodgkin’s lymphoma in an ...

BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for ...

The FDA has approved Tevimbra with chemotherapy for the first-line treatment of unresectable or metastatic ESCC whose tumors express PD-L1.